Literature DB >> 11128684

Image analysis quantification of substance P immunoreactivity in the trapezius muscle of patients with fibromyalgia and myofascial pain syndrome.

R De Stefano1, E Selvi, M Villanova, E Frati, S Manganelli, E Franceschini, G Biasi, R Marcolongo.   

Abstract

OBJECTIVE: Substance P (SP), a neurotransmitter stored within the afferent nociceptive fibers, is likely to be involved in the pathogenesis of musculoskeletal pain. We investigated SP immunoreactive (SP-ir) nerve fibers in the upper trapezius of patients with fibromyalgia (FM) and myofascial pain syndrome (MPS) by immunochemistry.
METHODS: Trapezius muscle obtained from tender points of 9 women with primary FM, from trigger points of 9 women with regional myofascial pain, and from 9 control women were immunostained with anti-SP sera. Quantitative evaluation was performed by computerized image analysis.
RESULTS: No significant differences in the number of SP-ir areas were detected between groups (one way ANOVA: p = 0.2); in contrast, mean optical density (OD) of SP-ir showed a significant difference comparing the groups (one way ANOVA: p < 0.0001). Mean OD of the immunostaining for SP was statistically greater in trapezius muscle of patients with MPS (0.594 +/- 0.096) compared to specimens from patients with FM (0.436 +/- 0.140) (p < 0.05) and controls (0.314 +/- 0.105) (p < 0.05); mean OD of immunostaining for SP was greater in FM specimens than in controls (p < 0.05).
CONCLUSION: Our results point to a peripheral hyperactivity of the peptidergic nervous system in FM as well as in MPS. These findings support the notion of pathogenetic involvement of the afferent nervous system in the development and perception of myofascial pain.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11128684

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  10 in total

Review 1.  Fibromyalgia: a rheumatologic diagnosis?

Authors:  Gerhard K M Endresen
Journal:  Rheumatol Int       Date:  2007-07-20       Impact factor: 2.631

Review 2.  [Mechanisms of muscle pain : significance of trigger points and tender points].

Authors:  H-P Brezinschek
Journal:  Z Rheumatol       Date:  2008-12       Impact factor: 1.372

3.  [Etiology and pathophysiology of fibromyalgia syndrome and chronic widespread pain].

Authors:  C Sommer; W Häuser; K Gerhold; P Joraschky; F Petzke; T Tölle; N Uçeyler; A Winkelmann; K Thieme
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

Review 4.  Botulinum toxin for the treatment of musculoskeletal pain and spasm.

Authors:  Geoffrey Sheean
Journal:  Curr Pain Headache Rep       Date:  2002-12

Review 5.  Evidence of involvement of central neural mechanisms in generating fibromyalgia pain.

Authors:  Roland Staud
Journal:  Curr Rheumatol Rep       Date:  2002-08       Impact factor: 4.592

Review 6.  Peripheral and central sensitization in fibromyalgia: pathogenetic role.

Authors:  Roland Staud; Michael L Smitherman
Journal:  Curr Pain Headache Rep       Date:  2002-08

7.  Fibromyalgia, myofascial pain, tender points and trigger points: splitting or lumping?

Authors:  Robert M Bennett; Don L Goldenberg
Journal:  Arthritis Res Ther       Date:  2011-06-30       Impact factor: 5.156

8.  Assessment of Myofascial Trigger Points via Imaging: A Systematic Review.

Authors:  Dario F Mazza; Robert D Boutin; Abhijit J Chaudhari
Journal:  Am J Phys Med Rehabil       Date:  2021-10-01       Impact factor: 3.412

9.  Nanocrystalline cerium dioxide efficacy for gastrointestinal motility: potential for prokinetic treatment and prevention in elderly.

Authors:  Olena Yu Yefimenko; Yuliya O Savchenko; Tetyana M Falalyeyeva; Tetyana V Beregova; Nadiya M Zholobak; Mykola Ya Spivak; Oleksandr B Shcherbakov; Rostyslav V Bubnov
Journal:  EPMA J       Date:  2015-03-11       Impact factor: 6.543

Review 10.  Understanding migraine: Potential role of neurogenic inflammation.

Authors:  Rakesh Malhotra
Journal:  Ann Indian Acad Neurol       Date:  2016 Apr-Jun       Impact factor: 1.383

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.